XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 169,023 $ 145,054
Marketable securities 167,286 152,167
Total cash, cash equivalents, and marketable securities 336,309 297,221
Accounts receivable, net 168,795 255,150
Unbilled receivables, net 199,948 213,719
Other current assets 71,438 80,388
Total current assets 776,490 846,478
Unbilled receivables, net 73,795 95,806
Goodwill 81,437 81,399
Other long-term assets 290,807 333,989
Total assets 1,222,529 1,357,672
Current liabilities:    
Accounts payable 20,541 18,195
Accrued expenses 43,624 50,355
Accrued compensation and related expenses 93,511 127,728
Deferred revenue 297,067 325,212
Other current liabilities 18,038 17,450
Total current liabilities 472,781 538,940
Convertible senior notes, net 498,753 593,609
Operating lease liabilities 68,874 79,152
Other long-term liabilities 14,485 15,128
Total liabilities 1,054,893 1,226,829
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Preferred stock, 1,000 shares authorized; none issued 0 0
Common stock, 200,000 shares authorized; 83,523 and 82,436 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 835 824
Additional paid-in capital 343,259 229,602
Accumulated deficit (151,370) (76,513)
Accumulated other comprehensive (loss) (25,088) (23,070)
Total stockholders’ equity 167,636 130,843
Total liabilities and stockholders’ equity $ 1,222,529 $ 1,357,672